MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial

Go back to MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
Medicinova, Inc. (NASDAQ: MNOV) Delayed: 1.72 -0.86 (33.33%)
Previous Close $2.58    52 Week High $10.16 
Open $2.40    52 Week Low $2.91 
Day High $2.45    P/E N/A 
Day Low $1.69    EPS $-0.41 
Volume 1,085,031